Loading...
Bilateral Trade Intelligence · $1.5K Total Trade · 4 Foreign Suppliers · 3 Indian Buyers · DGFT Verified · Updated March 2026
India imported $1.5K worth of pharmaceutical formulations from Serbia across 10 verified shipments, from 4 foreign suppliers to 3 Indian buyers. The top suppliers are HEMOFARM RD ($698) and HEMOFARM AD ($579). The leading products are Tramadol ($1K) and Dapagliflozin ($93). Average shipment value: $146.
| # | Formulation | Value | Share |
|---|---|---|---|
| 1 | Tramadol | $1.3K | 87.2% |
| 2 | Dapagliflozin | $93 | 6.3% |
| 3 | Metformin | $93 | 6.3% |
| 4 | Ibuprofen | $2 | 0.1% |
India imports 4+ pharmaceutical formulations from Serbia with a combined trade value of $1.5K. Key products include Tramadol ($1K), Dapagliflozin ($93), Metformin ($93), Ibuprofen ($2). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 10 verified Indian Customs (DGFT) shipment records.
These are the top pharmaceutical products exported from India to Serbia, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Serbia buyers, regulatory requirements, and logistics for that specific product corridor. Products include Tramadol ($1K), Dapagliflozin ($93), Metformin ($93), Ibuprofen ($2) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.
4 Indian pharmaceutical companies export finished formulations to Serbia. Leading exporters include Hemofarm Rd, Hemofarm Ad, Hemofarm A.d., M/s. Galenika Ad. The top exporter accounts for 47.6% of total India–Serbia pharma exports. Source: Indian Customs (DGFT).
India exported pharmaceuticals worth $1.5K to Serbia across 10 verified shipments.
1. HEMOFARM RD — $698. 2. HEMOFARM AD — $579. 3. HEMOFARM A.D. — $186. Total: 4 suppliers.
1. CLIANTHA RESEARCH LIMITED — $1.3K. 2. VEEDA CLINICAL RESEARCH LIMITED — $186. 3. SYNGENE INTERNATIONAL LIMITED — $2. 3 buyers total.
1. Tramadol ($1.3K, 87.2%); 2. Dapagliflozin ($93, 6.3%); 3. Metformin ($93, 6.3%); 4. Ibuprofen ($2, 0.1%)
Export: . Import: .
India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $1.5K corridor reflects quality compliance and pricing advantages.
WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.
3 companies in Serbia import pharmaceutical formulations from India. Top buyers include Cliantha Research Limited, Veeda Clinical Research Limited, Syngene International Limited, . The largest buyer accounts for 87.2% of India–Serbia pharma imports. Source: Indian Customs (DGFT).
$146 per consignment across 10 shipments.
4 Indian companies. Largest: HEMOFARM RD with $698.
TransData Nexus covers 4 active exporters with shipment history and trade values at transdatanexus.com.
Access complete shipment records, supplier intelligence, buyer histories, and price analytics for all 10 shipments.
Data sourced from Indian Customs (DGFT) records. Verify regulatory status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
4 Exporters
3 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists